A preliminary study on the delivery of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) at high risk of HIV transmission through the application of a self-financed incentivized approach
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 17 Dec 2017 Status changed from not yet recruiting to recruiting.
- 27 Oct 2016 New trial record